Use of Synvisc® in Knee Osteoarthritis - Medico-economical Study

N/ACompletedNCT02195505

Boehringer Ingelheim374 enrolled

Overview

The USAGE study aims at assessing on a long-term period (two years in average) the outcome in clinical or economical term of patients with knee osteoarthritis (OA) treated or not with Synvisc®, in the 1139.4 clinical trial.

Study Type

OBSERVATIONAL

Enrollment

374

Conditions

Osteoarthritis

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Patients have already been followed up on a nine-month period in a pragmatic medica-economical clinical trial (BI Trial No.: 1139.4) Exclusion Criteria: * none

Outcomes

Primary Outcomes

Change in Lequesne index

assessment of algo-functional severity of pathology

Time frame: up to 2 years

Change in Womac index

assessment of symptom severity

Time frame: up to 2 years

Secondary Outcomes

Medical costs related to knee osteoarthritis

Time frame: up to 2 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.